- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Aptinyx reports positive data from Phase II trial of NYX-783 for PTSD

Based on these results, Aptinyx plans to initiate a first pivotal study next year. Credit: Jude Beck on Unsplash.